English | Español

Biospace
Patient Daily | Mar 4, 2026

Biopharma workers reconsider career moves as job market shows signs of stabilization
Patient Daily | Mar 4, 2026

CDC’s principal deputy director Ralph Abraham resigns amid leadership changes
Patient Daily | Mar 4, 2026

Merck restructures human health division ahead of Keytruda patent expiration
Patient Daily | Mar 4, 2026

Vanda receives FDA approval for new antipsychotic after previous setback
Patient Daily | Mar 4, 2026

FDA proposes regulatory path for individualized gene editing therapies targeting rare diseases
Patient Daily | Mar 4, 2026

Congress approves record $315 million for ALS research amid new treatment efforts
Patient Daily | Mar 4, 2026

Appellate court rules for REGENXBIO over Sarepta in gene therapy patent case
Patient Daily | Mar 4, 2026

Novo Nordisk’s obesity drug fails key test against Eli Lilly rival

Trending
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
+ Regulatory
Patient Daily | Mar 9, 2026

Pharmacy owner Kiefer on PBMs: 'Independent pharmacies are being aggressively pushed out of business by the monopolistic practices of PBMs'
+ Pharmaceuticals
Patient Daily | Mar 9, 2026

Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research